Expert synthesis of the literature to support critical care decision making

Journal of the Medical Library Association

Volumn 94, Issue 4, 2006, Pages 376-381

  Jerome, Rebecca N ^a   Miller, Randolph A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Professor of Biomedical Informatics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIMETHATE; COLISTIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULBACTAM; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DECISION MAKING; DRUG BINDING; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG WITHDRAWAL; ENTEROBACTER INFECTION; GRAM NEGATIVE INFECTION; HEPATIC ENCEPHALOPATHY; HUMAN; INTENSIVE CARE; KIDNEY DISEASE; KIDNEY FAILURE; LIVER FAILURE; MEDICAL LITERATURE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NEUROTOXICITY; PNEUMONIA; RESPIRATORY FAILURE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 33751501722     PISSN: 15365050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. AMERICAN THORACIC SOCIETY, INFECTIOUS DISEASES SOCIETY OF AMERICA. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005 Feb 15;171(4):388-416.
2. SAFDAR N, DEZFULIAN C, COLLARD HR, SAINT S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005 Oct;33(10):2184-93.
3. Respiratory failure. In: Merck manual home edition. [Web document]. Whitehouse Station, NJ: Merck Research Laboratories, 2005. [rev. 1 Feb 2003; cited 13 Jun 2006]. 〈http:// www.merck.com/mmhe/sec04/ch055/ch055a. html〉.
4. CENTERS FOR DISEASE CONTROL AND PREVENTION. Overview of pneumonia in healthcare settings. [Web document]. Atlanta, GA: The Centers, 2004. [rev. 25 Mar 2004; cited 13 Jun 2006]. 〈http://www.cdc.gov/ncidod/dhqp/id_pneumonia. html〉.
5. Hospital-acquired pneumonia. In: MedlinePlus medical encyclopedia. [Web document]. Atlanta, GA: A.D.A.M., 2006. [rev. 7 Nov 2005; cited 13 Jun 2006]. 〈http://www.nlm. nih.gov/medlineplus/ency/article/000146.htm〉.
6. Hospital-acquired and institutional-acquired pneumonia. In: Merck manual home edition. [Web document]. Whitehouse Station, NJ: Merck Research Laboratories, 2005. [rev. 1 Feb 2003; cited 13 Jun 2006]. 〈http://www. merck.com/ mmhe/print/sec04/ch042/ch042c.html〉.
7. CENTERS FOR DISEASE CONTROL AND PREVENTION. Overview of drug resistant Acinetobacter infections in healthcare settings. [Web document]. Atlanta, GA: The Centers, 2004. [rev. 24 Sept 2004; cited 13 Jun 2006]. 〈http://www.cdc. gov/ncidod/dhqp/ar_acinetobacter.html〉.
8. Gram staining. In: Wikipedia. [Web document]. [rev. 10 Jun 2006; cited 13 Jun 2006]. 〈http://en.wikipedia.org/ wiki/Gram_staining〉.
9. Liver failure. [Web document]. Cleveland, OH: Cleveland Clinic Foundation, 2006. [cited 13 Jun 2006]. 〈http://www. clevelandclinic.org/ health/health-info/docs/3300/3368 .asp?index=9494〉.
10. Hepatic encephalopathy. In: MedlinePlus medical encyclopedia. [Web document]. Atlanta, GA: A.D.A.M., 2006. [rev. 10 Nov 2004; cited 13 Jun 2006]. 〈http://www.nlm.nih.gov/ medlineplus/ency/article/000302.htm〉.
11. Fiberoptic bronchoscopy. [Web document]. American Thoracic Society, 2004. [cited 13 Jun 2006]. 〈http://www.thoracic.org/sections/education/patient- education/patient-education-materials/patient-information-series/ fiberoptic-bronchoscopy.html〉.
12. Bronchoscopy. In: MedlinePlus medical encyclopedia. [Web document]. Atlanta, GA: A.D.A.M., 2006. [rev. 2 Mar 2006; cited 13 Jun 2006]. 〈http://www.nlm.nih.gov/ medlineplus/ency/article/003857.htm〉.
13. Bronchoalveolar lavage. In: Wikipedia. [Web document]. [rev. 18 Apr 2006; cited 13 Jun 2006]. 〈http://en. wikipedia.org/wiki/ Bronchoalveolar_lavage〉.
14. VYAS JM, FERRARO MJ. Overview of antibacterial susceptibility testing. In: UpToDate. [Web document]. Waltham, MA: UpToDate, 2006. [rev. 6 Jan 2004; cited 13 Jun 2006]. 〈http://www.uptodate.com〉.
15. Polymyxins. In: AHFS drug information. Bethesda, MD: American Society of Hospital Pharmacists, 2006.
16. GARNACHO-MONTERO J, ORTIZ-LEYBA C, JIMENEZ-JIMENEZ FJ, BARRERO-ALMODOVAR AE, GARCIA-GARMENDIA JL, BERNABEU-WITTELI M, GALLEGO-LARA SL, MADRAZO-OSUNA J. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003 May 1;36(9):1111-8.
17. KASIAKOU SK, MICHALOPOULOS A, SOTERIADES ES, SAMONIS G, SERMAIDES GJ, FALAGAS ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005 Aug;49(8):3136-46.
18. REINA R, ESTENSSORO E, SAENZ G, CANALES HS, GONZALVO R, VIDAL G, MARTINS G, DAS NEVES A, SANTANDER O, RAMOS C. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 2005 Aug;31(8):1058-65.
19. MICHALOPOULOS AS, TSIODRAS S, RELLOS K, MENTZELOPOULOS S, FALAGAS ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005 Feb;11(2):115-21.
20. FALAGAS ME, KASIAKOU SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005 May 1; 40(9):1333-41.
21. JAIN R, DANZIGER LH. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 2004 Sep;38(9):1449-59.
22. FERRARA AM. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int J Antimicrob Agents 2006 Mar;27(3):183-95.
23. MCALISTER FA, CLARK HD, VAN WALRAVEN C, STRAUS SE, LAWSON FM, MOHER D, MULROW CD. The medical review article revisited: has the science improved? Ann Intern Med 1999 Dec 21;131(12):947-51.
24. FALAGAS ME, KASIAKOU SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006 Feb 13;10(1):R27.
25. SUEKE H, MARSH H, DHITAL A. Using intrathecal colistin for multidrug resistant shunt infection. Br J Neurosurg 2005 Feb;19(1):51-2.
26. MICHALOPOULOS A, KASIAKOU SK, MASTORA Z, RELLOS K, KAPASKELIS AM, FALAGAS ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005 Feb;9(1):R53-9.